Value: The Next Frontier in Cancer Care-Reference-Cited by-同舟云学术

Value: The Next Frontier in Cancer Care

Published:2016-05-25 Issue:6 Volume:21 Page:651-653
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Goulart Bernardo H.L.¹

Affiliation:

1. University of Washington, Seattle, Washington, USA; Hutchinson Institute of Cancer Outcomes Research, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Abstract

Given the urgency to balance the delivery of high-quality cancer care with costs, stakeholders are developing new models of care delivery and reimbursement that emphasize value. The Value in Cancer Care series is a collection of 11 opinion-based articles that jointly aim to inform practicing oncologists about the pertinent facets of the value debate.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2016-0174

Reference27 articles.

1. Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: The John Conley Lecture;Fojo;JAMA Otolaryngol Head Neck Surg,2014

2. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

3. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

4. Projections of the cost of cancer care in the United States: 2010-2020;Mariotto;J Natl Cancer Inst,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The correlation between the costs and clinical benefits of PD-1/PD-L1 inhibitors in malignant tumors: An evaluation based on ASCO and ESMO frameworks;Frontiers in Pharmacology;2023-02-23

2. Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1;Acta Oncologica;2021-06-29

3. Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer;International Journal of Particle Therapy;2021-06-01

4. A Financial Theory Perspective of the Metrics Employed to Measure Value in the “Value in Healthcare” Methodologies;Portuguese Journal of Public Health;2021-01-07

5. Personalized Clinical Research: Childhood Cancer Survivor and Parent Preferences for Research Participation;JCO Oncology Practice;2020-12